Over half of respondents (55%) are unsure or do not know that their chronic health condition may increase their risk of developing shingles Majority (77%) fear disruption to daily life… Read More
An international collaboration involving UBC researchers has been awarded $2M to use AI to identify factors tied to long-term survival. Gene-editing tools like CRISPR have unlocked new treatmUBC researchers are… Read More
VICTORIA, BC – Eupraxia Pharmaceuticals Inc. a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased… Read More
Decision overlooks compelling evidence that LEQEMBI ® (lecanemab-irmb) meaningfully slows the progression of Alzheimer’s disease and preserves ability to perform activities of daily living for those in the early stages of… Read More
The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use. LAVAL, QC – Bausch Health Companies Inc., and its dental products… Read More
